We are live on ! Find out more
First Quadrant

First Quadrant Portfolio holdings

AUM $18M Turnover 89.22%
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.39%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.7 years

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.39%
2 Technology 15.39%
3 Healthcare 14.54%
4 Industrials 13.4%
5 Energy 11.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TRIP icon
76
TripAdvisor
TRIP
$851M
$18.1M 0.4%
167,000
– –
2013 Q4
2 quarters
DDS icon
77
Dillards
DDS
$9.02B
$18M 0.4%
154,135
+91,400
+146% +$9.5M
2013 Q2
4 quarters
ESRX
78
DELISTED
Express Scripts Holding
ESRX
$17.9M 0.4%
258,760
+147,400
+132% +$10.4M
2013 Q2
4 quarters
BCR
79
DELISTED
CR Bard
BCR
$17.8M 0.4%
124,200
-23,500
-16% -$3.36M
2013 Q2
4 quarters
GAP icon
80
The Gap Inc
GAP
$6.97B
$17.7M 0.39%
425,425
– –
2013 Q2
4 quarters
HOG icon
81
Harley-Davidson
HOG
$3.37B
$17.6M 0.39%
+252,500
New +$17.8M
2014 Q2
0 quarters
RNR icon
82
RenaissanceRe
RNR
$14B
$17.3M 0.39%
162,100
+19,500
+14% +$2M
2013 Q2
4 quarters
WMT icon
83
Walmart
WMT
$1.01T
$17.2M 0.38%
688,914
-46,200
-6% -$1.19M
2013 Q2
4 quarters
PEG icon
84
Public Service Enterprise Group
PEG
$37.2B
$16.8M 0.37%
411,600
+600
+0.1% +$23.3K
2013 Q2
4 quarters
HES icon
85
DELISTED
Hess
HES
$16.4M 0.37%
166,030
+61,275
+58% +$5.53M
2013 Q2
4 quarters
SWKS icon
86
Skyworks Solutions
SWKS
$19.4B
$16.2M 0.36%
345,500
-5,800
-2% -$244K
2013 Q2
4 quarters
WSM icon
87
Williams-Sonoma
WSM
$30.6B
$16M 0.36%
+445,400
New +$14.6M
2014 Q2
0 quarters
CB icon
88
DELISTED
Chubb
CB
$15.9M 0.35%
172,887
– –
2013 Q2
4 quarters
BA icon
89
Boeing
BA
$129B
$15.7M 0.35%
123,300
-2,300
-2% -$300K
2013 Q2
4 quarters
SNI
90
DELISTED
Scripps Networks Interactive
SNI
$15.6M 0.35%
191,900
– –
2013 Q4
2 quarters
CI icon
91
Cigna
CI
$75.2B
$15.4M 0.34%
167,839
+99,000
+144% +$8.49M
2013 Q2
4 quarters
AIG icon
92
AIG
AIG
$42.1B
$15.1M 0.34%
276,176
– –
2013 Q2
4 quarters
HRL icon
93
Hormel Foods
HRL
$12.7B
$15.1M 0.34%
610,600
-10,200
-2% -$247K
2013 Q4
2 quarters
DOX icon
94
Amdocs
DOX
$4.51B
$14.8M 0.33%
319,800
-131,100
-29% -$6.17M
2013 Q2
4 quarters
GS icon
95
Goldman Sachs
GS
$252B
$14.6M 0.33%
87,360
-2,300
-3% -$371K
2013 Q2
4 quarters
KMB icon
96
Kimberly-Clark
KMB
$65.8B
$14.6M 0.32%
136,946
+6,049
+5% +$643K
2013 Q2
4 quarters
CFN
97
DELISTED
CareFusion
CFN
$14.6M 0.32%
328,450
– –
2013 Q2
4 quarters
TMO icon
98
Thermo Fisher Scientific
TMO
$257B
$14.5M 0.32%
122,712
-156,192
-56% -$18.4M
2013 Q2
4 quarters
LOW icon
99
Lowe's Companies
LOW
$125B
$14.2M 0.32%
296,400
-160,000
-35% -$7.46M
2013 Q2
4 quarters
DD icon
100
DuPont de Nemours
DD
$19.9B
$14.2M 0.32%
108,987
+18,480
+20% +$2.35M
2013 Q3
3 quarters

Similar funds

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited Bally Technologies in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.